Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$774M |
| 2 |
Intuitive Surgical
ISRG
|
+$654M |
| 3 |
S&P Global
SPGI
|
+$464M |
| 4 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$326M |
| 5 |
CELG
Celgene Corp
CELG
|
+$243M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FedEx
FDX
|
+$591M |
| 2 |
Broadcom
AVGO
|
+$550M |
| 3 |
Monster Beverage
MNST
|
+$408M |
| 4 |
Booking.com
BKNG
|
+$377M |
| 5 |
McDonald's
MCD
|
+$371M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.49% |
| 2 | Consumer Discretionary | 16.46% |
| 3 | Healthcare | 15.81% |
| 4 | Financials | 12.97% |
| 5 | Communication Services | 11.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ONC
576
BeOne Medicines Ltd
ONC
$41.5B
| $762K | ﹤0.01% |
4,427
+43
| +1% | +$7.23K |
|
577
Nektar Therapeutics
NKTR
$2.48B
| $758K | ﹤0.01% |
+829
| New | +$708K |
|
578
WSFS Financial
WSFS
$4B
| $754K | ﹤0.01% |
15,997
-176,476
| -92% | -$9.08M |
|
|
TBI
579
Trueblue
TBI
$326M
| $753K | ﹤0.01% |
28,910
-357
| -1% | -$9.91K |
|
580
Sabra Healthcare REIT
SBRA
$5.27B
| $748K | ﹤0.01% |
+32,366
| New | +$733K |
|
|
EPAY
581
DELISTED
Bottomline Technologies Inc
EPAY
| $747K | ﹤0.01% |
+10,275
| New | +$628K |
|
582
BJ's Restaurants
BJRI
$1.39B
| $742K | ﹤0.01% |
10,276
-125
| -1% | -$8.39K |
|
583
Phillips 66
PSX
$97.4B
| $737K | ﹤0.01% |
6,534
+1,463
| +29% | +$169K |
|
584
Occidental Petroleum
OXY
$59.1B
| $736K | ﹤0.01% |
8,952
+726
| +9% | +$58.7K |
|
585
International Bancshares
IBOC
$4.41B
| $732K | ﹤0.01% |
+16,263
| New | +$742K |
|
586
Cheesecake Factory
CAKE
$5.58B
| $717K | ﹤0.01% |
13,392
-318
| -2% | -$17.2K |
|
587
United Natural Foods
UNFI
$2.77B
| $712K | ﹤0.01% |
23,788
-8,149
| -26% | -$295K |
|
|
TSS
588
DELISTED
Total System Services, Inc.
TSS
| $712K | ﹤0.01% |
7,213
-148
| -2% | -$13.9K |
|
589
Watts Water Technologies
WTS
$12.2B
| $706K | ﹤0.01% |
8,500
-110
| -1% | -$9.11K |
|
590
Encompass Health
EHC
$11.9B
| $693K | ﹤0.01% |
11,182
-230
| -2% | -$14K |
|
591
Nucor
NUE
$56.8B
| $684K | ﹤0.01% |
10,781
+1,689
| +19% | +$108K |
|
592
Synchrony
SYF
$25.4B
| $681K | ﹤0.01% |
21,927
-4,650
| -17% | -$148K |
|
|
NCI
593
DELISTED
Navigant Consulting, Inc.
NCI
| $681K | ﹤0.01% |
+29,511
| New | +$683K |
|
594
NOV
NOV
$7.48B
| $679K | ﹤0.01% |
15,750
-1,234
| -7% | -$55.2K |
|
595
Yum! Brands
YUM
$42B
| $678K | ﹤0.01% |
7,454
-839
| -10% | -$70K |
|
596
Deckers Outdoor
DECK
$12B
| $673K | ﹤0.01% |
34,032
-18,372
| -35% | -$357K |
|
597
Etsy
ETSY
$7.67B
| $668K | ﹤0.01% |
13,007
-7,006
| -35% | -$323K |
|
|
VMW
598
DELISTED
VMware, Inc
VMW
| $665K | ﹤0.01% |
+4,262
| New | +$652K |
|
599
Sysco
SYY
$39.3B
| $664K | ﹤0.01% |
9,065
+38
| +0.4% | +$2.74K |
|
600
NeoGenomics
NEO
$2.32B
| $663K | ﹤0.01% |
43,163
-573
| -1% | -$7.92K |
|
Similar funds
Jennison Associates's Q3 2018 Portfolio in Review
As of Q3 2018, Jennison Associates held 739 positions worth $109B, up 5.9% from $103B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Jennison Associates's Q3 2018 filing shows 86 new, 214 increased, 352 reduced and 81 closed positions. Its largest new stake was Tiffany & Co.: 1,169,094 shares worth $151M. The largest sale was FedEx, an estimated $591M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Jennison Associates's largest Q3 2018 buy was Tiffany & Co.: 1,169,094 shares worth $151M.
- Jennison Associates added most to AstraZeneca in Q3 2018, an estimated $774M increase.
- Jennison Associates's biggest Q3 2018 reduction was FedEx, cutting an estimated $591M.
- Jennison Associates fully exited Cheniere Energy Partners LP Holdings LLC in Q3 2018, selling an estimated $134M.
- Jennison Associates's ten largest holdings make up 30% of its $109B portfolio in Q3 2018.
- Jennison Associates opened 86 new positions and closed 81 in Q3 2018.
- Jennison Associates's portfolio value rose 5.9% quarter-over-quarter to $109B.
Based on Jennison Associates's 13F filing for Q3 2018, filed 8 Nov 2018.